Pricing Log in Create free account

Fulcrum Therapeutics, Inc. (FULC) vs Kyverna Therapeutics, Inc. (KYTX)

Fulcrum Therapeutics, Inc. and Kyverna Therapeutics, Inc. are both Biotechnology companies. Fulcrum Therapeutics, Inc. and Kyverna Therapeutics, Inc. are of similar size ($285.1M and $280.8M). Across the 9 metrics below, Fulcrum Therapeutics, Inc. leads on 7 and Kyverna Therapeutics, Inc. on 2.

Valuation

Metric FULC KYTX Biotechnology median
P/E n/m n/m 10.60
P/S 3.43 n/m 9.40
P/B 0.91 1.78 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.38 n/m 0.66
EV/Sales (0.44) n/m 9.02
Earnings yield (32.61%) (60.62%) (32.88%)
Free cash flow yield (23.22%) (53.83%) (23.13%)

Profitability

Metric FULC KYTX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (32.38%) (87.24%) (51.96%)
Return on assets (30.75%) (68.40%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FULC KYTX Biotechnology median
Revenue growth (TTM) 1,939.80% — 6.76%
EPS growth (last fiscal year) (637.50%) (9.31%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric FULC KYTX Biotechnology median
Debt to equity 0.00 0.15 0.00
Current ratio 31.35 9.06 4.97
Net debt to EBITDA 4.23 1.51 1.01

Dividend

Metric FULC KYTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FULC KYTX Biotechnology median
Market cap 280.77m 285.10m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack